Clinical Trial Update: Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating intraportal infusion of autologous bone marrow mononuclear cells to enhance liver rege…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Rejection

Drugs mentioned

• Intraportal autologous bone marrow mononuclear cell infusion (autologous bone marrow mononuclear cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Liver Transplant Rejection | Phase 2 | Status: COMPLETED